CLEVELAND [April 23] /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in
developing cloud-based, unified eClinical® technologies and delivering related
services for the clinical trials industry, today announced an Israeli
biopharmaceutical company chose to standardize on the DATATRAK ONE™ clinical
research platform for its oncology program. Understanding the benefit of the
unified platform, they will utilize multiple products and modules within the
software suite – uEDC, including medical coding and uIRT, including both
Randomization and Clinical Supplies Management – to reduce the cost of their
clinical trials.



 



“Our new client has an exciting history of developing novel
immunotherapy drug products,” stated Laurence P. Birch, DATATRAK’s Chairman of
the Board and CEO. “Pairing our expansive technology with their innovative
approach to drug development, we are able to reduce costs across their oncology
drug program as well as accelerate their clinical trial timelines.”



 



DATATRAK
ONE™:



The DATATRAK
ONE™ Clinical Research Platform is an easy to use, cloud-based clinical
enterprise solution that empowers Sponsors and CROs to efficiently design,
deliver and manage clinical trials.  From
strategy and planning to resource management and study execution needs, clients
manage their entire product portfolio in a single system with one username and
password.  DATATRAK’s unified clinical enterprise solution consists of
seven products: uCTMS, uDesign, uEDC, uIRT, uSafety, uTrain and uCDR.



 



Join DATATRAK
Thought Leaders:




  • LinkedIn

  • SlideShare

  • The DATATRAK Blog

  • Facebook

  • Tweet: New
    Israeli Client Selects DATATRAK ONE™
    for Oncology Program     http://ow.ly/kjkmv












About
DATATRAK International, Inc.

DATATRAK
International is a worldwide technology and services company delivering unified
eClinical™ solutions and related services for the clinical trials industry. DATATRAK
built its multi-component, comprehensive solution on a single, unified platform
and expanded this concept to include services delivery via DATATRAK’s
Clinical and Consulting Services™ group. The Company delivers a complete
portfolio of software products designed to accelerate the reporting of clinical
research data from sites to sponsors and ultimately regulatory authorities,
faster and more efficiently than loosely integrated technologies. The DATATRAK
ONE™ software solution, deployed worldwide through an ASP or Enterprise
Transfer offering, supports Phase I – Phase IV drug and device studies in
multiple languages throughout the world. DATATRAK
has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North
Carolina. For more information, visit http://www.datatrak.net.



All
contracts are subject to possible delays or cancellation or can change in scope
in a positive or negative direction. Therefore, current backlog is not
necessarily indicative of the Company’s future quarterly or annual revenue.
Historically, backlog has been a poor predictor of the Company’s short-term
revenue.



Except
for the historical information contained in this press release, the statements
made in this release are forward-looking statements. These forward-looking
statements are made based on management’s expectations, assumptions, estimates
and current beliefs concerning the operations, future results and prospects of
the Company and are subject to uncertainties and factors which are difficult to
predict and, in many instances, are beyond the control of the Company, and
which could cause actual results to differ materially from those contemplated
in these forward-looking statements. For a list of certain factors that may
cause actual results to differ materially from those contemplated in these
forward looking statements, please see the Company’s report filed with the
OTCQX Market on March 15, 2013 announcing its results for the fourth
quarter and full year of 2012.
The Company undertakes no obligation to update publicly or revise any
forward-looking statement whether as a result of new information, future events
or otherwise.



Contact:

Lisa Pahl, Director Marketing, DATATRAK International, Inc.,
+1-979-393-9025


DataTRAK (PK) (USOTC:DTRK)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas DataTRAK (PK).
DataTRAK (PK) (USOTC:DTRK)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas DataTRAK (PK).